Outcomes and hemodynamics of Enable bioprosthesis in 432 patients: an afterword.
Konstantin ZhigalovMichel Pompeu Barros Oliveira SáIrakli GogiaOnise ChaduneliEl-Baraa AdjailiaAhmed MashhourJerry EasoDaniel WendtArjang RuhparwarOtto DapuntAlexander WeymannHarald C EichstaedtPublished in: Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy (2020)
The Enable sutureless prosthesis showed a reliable clinical outcome with low perioperative mortality and morbidity. The hemodynamic performance was satisfactory. Our data confirmed the safety of SAVR using the Enable bioprosthesis. However, a higher rate of pacemaker implantation (6.5%) has to be mentioned.
Keyphrases
- end stage renal disease
- aortic valve
- aortic valve replacement
- ejection fraction
- transcatheter aortic valve implantation
- newly diagnosed
- chronic kidney disease
- patients undergoing
- peritoneal dialysis
- cardiovascular events
- heart failure
- cardiac surgery
- risk factors
- metabolic syndrome
- patient reported outcomes
- adipose tissue
- coronary artery disease
- aortic stenosis
- transcatheter aortic valve replacement
- cardiovascular disease
- left ventricular
- artificial intelligence
- patient reported